135 related articles for article (PubMed ID: 9276154)
21. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
[TBL] [Abstract][Full Text] [Related]
22. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
Butt SK; Dawson LG; Hall JM
Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of bradykinin analogues on recombinant human bradykinin B(1) and B(2) receptors.
Simpson PB; Woollacott AJ; Hill RG; Seabrook GR
Eur J Pharmacol; 2000 Mar; 392(1-2):1-9. PubMed ID: 10748265
[TBL] [Abstract][Full Text] [Related]
24. HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats.
Bao G; Qadri F; Stauss B; Stauss H; Gohlke P; Unger T
Eur J Pharmacol; 1991 Jul; 200(1):179-82. PubMed ID: 1769370
[TBL] [Abstract][Full Text] [Related]
25. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
Fathy DB; Kyle DJ; Leeb-Lundberg LM
Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
[TBL] [Abstract][Full Text] [Related]
26. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.
Corrêa CR; Calixto JB
Br J Pharmacol; 1993 Sep; 110(1):193-8. PubMed ID: 8220879
[TBL] [Abstract][Full Text] [Related]
27. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
Field JL; Butt SK; Morton IK; Hall JM
Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
[TBL] [Abstract][Full Text] [Related]
28. Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists.
Stewart JM; Gera L; Chan DC; York EJ; Simkeviciene V; Bunn PA; Taraseviciene-Stewart L
Peptides; 2005 Aug; 26(8):1288-91. PubMed ID: 15878795
[TBL] [Abstract][Full Text] [Related]
29. Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin.
Oliveira EB; Martins AR; Camargo AC
Biochemistry; 1976 May; 15(9):1967-74. PubMed ID: 5120
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.
Meini S; Lecci A; Carini F; Tramontana M; Giuliani S; Maggi CA; Ricci R; Fabbri G; Anichini B; Harmat N; Rizzi A; Camarda V; Regoli D; Quartara L
Can J Physiol Pharmacol; 2002 Apr; 80(4):293-302. PubMed ID: 12025964
[TBL] [Abstract][Full Text] [Related]
31. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
Drube S; Liebmann C
Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
[TBL] [Abstract][Full Text] [Related]
32. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
33. New insights into the conformational requirements of B2 bradykinin antagonism.
Filizola M; Llorens O; Cartení-Farina M; Perez JJ
Bioorg Med Chem; 1998 Sep; 6(9):1491-500. PubMed ID: 9801820
[TBL] [Abstract][Full Text] [Related]
34. Agonist activity at the kinin B1 receptor: structural requirements of the central tetrapeptide.
Rovero P; Pellegrini M; Di Fenza A; Meini S; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mierke DF
J Med Chem; 2001 Jan; 44(2):274-8. PubMed ID: 11170638
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
Eur J Pharmacol; 1992 Mar; 225(3):235-44. PubMed ID: 1325366
[TBL] [Abstract][Full Text] [Related]
36. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
37. Potent bradykinin antagonists containing N-benzylglycine or N-benzyl-l-alanine in position 8.
Dawidowska O; Prahl A; Kowalczyk W; Derdowska I; Lammek B; Wierzba TH; Juzwa W; Neubert K; Zabrocki J; Olejniczak B
J Pept Res; 2004 Jan; 63(1):29-35. PubMed ID: 14984571
[TBL] [Abstract][Full Text] [Related]
38. B2 receptor-mediated enhanced bradykinin sensitivity of rat cutaneous C-fiber nociceptors during persistent inflammation.
Banik RK; Kozaki Y; Sato J; Gera L; Mizumura K
J Neurophysiol; 2001 Dec; 86(6):2727-35. PubMed ID: 11731532
[TBL] [Abstract][Full Text] [Related]
39. A rational approach to the design and synthesis of a new bradykinin B(1) receptor antagonist.
Bedos P; Amblard M; Subra G; Dodey P; Luccarini JM; Paquet JL; Pruneau D; Aumelas A; Martinez J
J Med Chem; 2000 Jun; 43(12):2387-94. PubMed ID: 10882365
[TBL] [Abstract][Full Text] [Related]
40. Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.
Lin KS; Amouroux G; Pan J; Zhang Z; Jenni S; Lau J; Liu Z; Hundal-Jabal N; Colpo N; Bénard F
J Nucl Med; 2015 Apr; 56(4):622-7. PubMed ID: 25745086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
